Bosi A - Search Results

1

Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab.

Petrarca A, Rigacci L, Monti M, Giannini C, Bernardi F, Caini P, Colagrande S, Bosi A, Laffi G, Zignego AL. Petrarca A, et al. Among authors: bosi a. Dig Liver Dis. 2007 Sep;39 Suppl 1:S129-33. doi: 10.1016/s1590-8658(07)80025-9. Dig Liver Dis. 2007. PMID: 17936214

2

Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease.

Petrarca A, Rigacci L, Caini P, Colagrande S, Romagnoli P, Vizzutti F, Arena U, Giannini C, Monti M, Montalto P, Matucci-Cerinic M, Bosi A, Laffi G, Zignego AL. Petrarca A, et al. Among authors: bosi a. Blood. 2010 Jul 22;116(3):335-42. doi: 10.1182/blood-2009-11-253948. Epub 2010 Mar 22. Blood. 2010. PMID: 20308604 Free article.

3

Dose-dense CHOP plus rituximab (R-CHOP14) for the treatment of elderly patients with high-risk diffuse large B cell lymphoma: a pilot study.

Rigacci L, Nassi L, Alterini R, Carrai V, Longo G, Bernardi F, Martini V, Bosi A. Rigacci L, et al. Among authors: bosi a. Acta Haematol. 2006;115(1-2):22-7. doi: 10.1159/000089461. Acta Haematol. 2006. PMID: 16424645 Clinical Trial.

4

Liposome-encapsulated doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab in patients with lymphoma and concurrent cardiac diseases or pre-treated with anthracyclines.

Rigacci L, Mappa S, Nassi L, Alterini R, Carrai V, Bernardi F, Bosi A. Rigacci L, et al. Among authors: bosi a. Hematol Oncol. 2007 Dec;25(4):198-203. doi: 10.1002/hon.827. Hematol Oncol. 2007. PMID: 17654614 Clinical Trial.

5

Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas.

Rigacci L, Nassi L, Puccioni M, Mappa S, Polito E, Dal Pozzo S, Alterini R, Carrai V, Puccini B, Bosi A. Rigacci L, et al. Among authors: bosi a. Ann Hematol. 2007 Aug;86(8):565-8. doi: 10.1007/s00277-007-0301-y. Epub 2007 May 5. Ann Hematol. 2007. PMID: 17483948 Clinical Trial.

6

Efficacy and safety of rituximab plus low-dose oral fludarabine and cyclophosphamide as first-line treatment of elderly patients with indolent non-Hodgkin lymphomas.

Fabbri A, Cencini E, Rigacci L, Bartalucci G, Puccini B, Dottori R, Gozzetti A, Bosi A, Bocchia M. Fabbri A, et al. Among authors: bosi a. Leuk Lymphoma. 2014 Apr;55(4):781-5. doi: 10.3109/10428194.2013.826354. Epub 2014 Jan 24. Leuk Lymphoma. 2014. PMID: 23876098 Clinical Trial.

7

Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas.

Fabbri A, Cencini E, Alterini R, Rubegni P, Rigacci L, Delfino C, Puccini B, Fimiani M, Bosi A, Bocchia M, Pimpinelli N; Gruppo Italiano Linfomi Cutanei (GILC). Fabbri A, et al. Among authors: bosi a. Eur J Haematol. 2014 Aug;93(2):129-36. doi: 10.1111/ejh.12315. Epub 2014 Apr 4. Eur J Haematol. 2014. PMID: 24635751

8

Oxaliplatin-based chemotherapy (dexamethasone, high-dose cytarabine, and oxaliplatin)±rituximab is an effective salvage regimen in patients with relapsed or refractory lymphoma.

Rigacci L, Fabbri A, Puccini B, Chitarrelli I, Chiappella A, Vitolo U, Levis A, Lauria F, Bosi A. Rigacci L, et al. Among authors: bosi a. Cancer. 2010 Oct 1;116(19):4573-9. doi: 10.1002/cncr.25216. Cancer. 2010. PMID: 20572029 Free article.

9

Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study.

Rigacci L, Carrai V, Nassi L, Alterini R, Longo G, Bernardi F, Bosi A. Rigacci L, et al. Among authors: bosi a. Cancer. 2005 Mar 1;103(5):970-7. doi: 10.1002/cncr.20891. Cancer. 2005. PMID: 15666323 Free article.

10

Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL).

Rigacci L, Puccini B, Cortelazzo S, Gaidano G, Piccin A, D'Arco A, Freilone R, Storti S, Orciuolo E, Zinzani PL, Zaja F, Bongarzoni V, Balzarotti M, Rota-Scalabrini D, Patti C, Gobbi M, Carpaneto A, Liberati AM, Bosi A, Iannitto E. Rigacci L, et al. Among authors: bosi a. Ann Hematol. 2012 Jul;91(7):1013-22. doi: 10.1007/s00277-012-1422-5. Epub 2012 Feb 15. Ann Hematol. 2012. PMID: 22349722

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters